PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 14 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $55,000 | -9.8% | 30,000 | 0.0% | 0.00% | – |
Q3 2018 | $61,000 | +41.9% | 30,000 | 0.0% | 0.00% | – |
Q2 2018 | $43,000 | +2.4% | 30,000 | 0.0% | 0.00% | – |
Q1 2018 | $42,000 | -26.3% | 30,000 | 0.0% | 0.00% | – |
Q4 2017 | $57,000 | +16.3% | 30,000 | 0.0% | 0.00% | – |
Q3 2017 | $49,000 | -18.3% | 30,000 | 0.0% | 0.00% | – |
Q2 2017 | $60,000 | +5.3% | 30,000 | 0.0% | 0.00% | – |
Q1 2017 | $57,000 | +32.6% | 30,000 | 0.0% | 0.00% | – |
Q4 2016 | $43,000 | -4.4% | 30,000 | 0.0% | 0.00% | – |
Q3 2016 | $45,000 | 0.0% | 30,000 | 0.0% | 0.00% | – |
Q2 2016 | $45,000 | -27.4% | 30,000 | +3.4% | 0.00% | – |
Q1 2016 | $62,000 | -8.8% | 29,000 | +31.8% | 0.00% | – |
Q4 2015 | $68,000 | +106.1% | 22,000 | +10.0% | 0.00% | – |
Q3 2015 | $33,000 | -42.1% | 20,000 | 0.0% | 0.00% | – |
Q2 2015 | $57,000 | -60.4% | 20,000 | -50.0% | 0.00% | – |
Q1 2015 | $144,000 | +166.7% | 40,000 | +166.7% | 0.00% | – |
Q4 2014 | $54,000 | – | 15,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EQUITEC SPECIALISTS, LLC | 3,000,000 | $4,524,000 | 1.31% |
Myriad Asset Management Ltd. | 10,000,000 | $14,880,000 | 0.95% |
WHITEBOX ADVISORS LLC | 11,350,000 | $17,117,000 | 0.71% |
WOLVERINE ASSET MANAGEMENT LLC | 21,743,000 | $32,797,000 | 0.49% |
MIZUHO SECURITIES USA LLC | 3,500,000 | $5,275,000 | 0.44% |
Verition Fund Management LLC | 1,160,000 | $1,755,000 | 0.19% |
CSS LLC/IL | 1,500,000 | $2,245,000 | 0.11% |
PALISADE CAPITAL MANAGEMENT, LP | 982,000 | $1,473,000 | 0.05% |
Citadel Advisors | 30,050,000 | $45,358,000 | 0.05% |
LAZARD ASSET MANAGEMENT LLC | 9,000,000 | $13,618,000 | 0.03% |